Regeneration of adult skeletal muscle after injury is coordinated by complex interactions between the injured muscle and the innate immune system. Myeloid lineage cells predominate in this process. This study examined the role of Krüppel -like factor 2 (KLF2), a zinc-finger transcription factor that regulates myeloid cell activation state, in muscle regeneration. Gastrocnemius muscles of wild-type and myeKlf2 -/-mice, which lack KLF2 in all myeloid cells, were subjected to cardiotoxin injury and followed for 21
lack KLF2 in all myeloid cells, were subjected to cardiotoxin injury and followed for 21 days. Injured muscles of myeKlf2 -/-contained more infiltrating, inflammatory Ly6C 
Introduction
Adult skeletal muscles retain a remarkable capacity to regenerate lost or damaged tissue. Skeletal muscle regeneration after acute injury progress through two main, overlapping phases, broadly defined as an initial proinflammatory phase followed by an anti-inflammatory, regenerative phase [1] [2] [3] [4] [5] . The regenerative phase recapitulates in many ways the process of embryonic myogenesis, while the immune response is unique to adult skeletal muscles. The immune response is essential for proper completion of repair [6] .
Muscle regeneration after injury is orchestrated by coordinated interactions between skeletal muscle and the innate immune system. Myeloid lineage immune cells play a central role in this process [4, 5, [7] [8] [9] . Indeed, depletion of circulating monocytes slows regeneration and reconstitution of myeloid lineage cells restores regeneration [10] .
Myeloid lineage monocytes dominate the initial inflammatory infiltrate, and are present at up to 100,000 cells/mm 3 of muscle [11] . As regeneration progresses, myeloid cells assume a continuum of activated phenotypes that support each phase of repair [7, 12] .
Macrophages remove necrotic tissue, secrete cytokines, chemokines, and growth factors, induce production of the fibrotic scaffold and blood supply needed for the growth and attachment of new fibers, help resolve the inflammation, and support the growth and differentiation of new myofibers [5, 13] . Macrophages eventually disappear as regeneration is completed and newly formed fibers with adult phenotypes are integrated into the muscle syncytium. The molecular mechanisms and signaling molecules that determine myeloid lineage phenotypes and functions during skeletal muscle repair remain poorly understood.
The zinc-finger transcription factor, KLF2, plays a central role in the activation and phenotypic determination of a variety of immune cell types, both lymphoid and myeloid [14] [15] [16] . KLF2 is a central, negative regulator of gene clusters which mediate the proinflammatory activation of monocytes and macrophages in vitro [17] , and its loss promotes an inflammatory monocyte/macrophage profile in vitro and in vivo [15, 18, 19] .
Macrophages of mice which lack KLF2 in all myeloid cells assume an enhanced inflammatory profile, with elevated expression of inflammatory mediators and greater infiltration into atherosclerotic plaques [18, 19] . in myeloid lineage cells may be a useful therapeutic strategy for immune-based therapies to improve outcomes after muscle injury.
Results

Loss of KLF2 in myeloid-derived cells enhances the inflammatory immune
response to muscle injury. The proinflammatory phase of muscle regeneration after acute injury is marked by significantly increased levels of inflammatory mediators, many of which are produced within the muscle by myeloid-derived monocytes and macrophages. To investigate the role of myeloid KLF2 in their production, we compared expression of the proinflammatory mediators -Cox2, IL-6, Ccl2, Ccl4, Ccl5, and Tnfα -in regenerating gastrocnemius muscles of WT and myeKlf2 -/-mice at days 3 and 5
post-CTX or -vehicle treatment ( Fig. 1 ). This was found to be the period when the greatest differences between WT and myeKlf2 -/-were seen.
Each of these cytokines/chemokines plays a known role in inflammation and regeneration. IL-6 is one of the earliest cytokines detected after acute muscle injury and the majority of IL-6 is produced by monocytes recruited from the circulation [20] . The signaling cytokines, Ccl2, Ccl4, and Ccl5, are released from the injured tissue and are also secreted by infiltrating monocytes. Ccl2 is regulated by KLF2 via miR124a and miR150 [18] . The cytokines TNFα and COX2, which mediate inflammation through prostaglandins, originate from activated, macrophages that matured in situ from infiltrating monocytes. Cox2 signaling is essential during the early stages of skeletal muscle regeneration [21] .
In injured muscles of WT mice, IL-6, Ccl2, Ccl4, Ccl5, and Tnfα are present at day 3 post injury ( Fig. 1A ) and decline by day 5 (Fig.1C) .Their appearance indicates that recruitment and infiltration of circulating monocytes is underway. Their decline by day 5
indicates that inflammation is resolving. Expression of Tnfα indicates that some of the infiltrating monocytes have matured into activated, proinflammatory macrophages.
Injured muscles of myeKlf2 -/-mice express these markers at 15 to 30-fold greater levels than WT at day 3 post injury (Fig. 1B) ; all but Ccl5 remain significantly elevated at day 5
( Fig 1D) , a time when their expression has returned to near baseline in WT. with a previous report that injured skeletal muscles recruit only Ly6C + monocytes from the circulation [5] .
By day 5, the Ly6C + population declines in both genotypes ( Fig gene, which has consensus KLF2 binding sequences [16] . Interestingly, CCR5 is the cytokine receptor for CCL4 (MIP1β) and CCL5 (RANTES), both of which are dramatically elevated in injured muscles of myeKlf2 -/-mice ( Fig. 1 ).
The number of cells expressing CCR5 is significantly greater in regenerating muscles of myeKlf2 -/-compared to WT on day 3 post injury (73% in myeKlf2 -/-vs. 61.2%
in WT samples; n = 5; p< 0.05; Fig. 4A ). This cell population remains elevated on day 5
in myeKlf2 -/-samples (45.3% in myeKlf2 -/-vs. 26.8% in WT, n = 5; p<0.05), but declines sharply after day 3 in WT.
KLF2 deficiency does not change the quantity of intramuscular CCR2-expressing cells on days 3 or 5 post injury (Fig. 4B ). CCR2 is a receptor for the ligand CCL2, which is highly upregulated at early times in CTX-treated myeKlf2 -/-muscle samples (Fig 1) .
This finding suggests that KLF2 regulation of cytokine receptor expression during muscle regeneration is receptor -specific.
We also compared expression of the C-mer receptor tyrosine kinase, MerTK, in regenerating WT and myeKlf2 -/-muscle samples (Fig. 4C ). MerTK defines a monocyte/macrophage phenotype that plays a role in resolving inflammation in other immune conditions [24, 25] . MerTK expression is elevated at day 3 in myeKlf2 Myf6 are the earliest expressed MRFs [26] . The appearance of these myogenic markers denotes the presence of activated satellite cells and newly forming fibers.
Regenerating muscles of myeKlf2 -/-mice express these markers earlier and at higher levels. Pax7, MyoD, and MyoG are already expressed at day 3 ( Fig. 5B ), are elevated 3-to 5-fold at day 5 ( Fig. 5D) , and remain elevated through day 8 (data not shown). Expression of Myf5 is increased by day 5 in myeKlf2 -/-mice.
Regeneration is advanced and completed normally in injured muscles of myeKlf2 -/-mice. To determine the consequences of these differences on the progression of muscle regeneration, we compared the histology of regenerating muscles of WT and myeKlf2 -/-mice ( To further quantify the progress of regeneration in WT and myeKlf2 -/-mice, we compared two indices of fiber maturation, mean cross-sectional areas and mean number of fibers with central nuclei at day 14 ( Fig. 6B, 6C ). Compared to WT, regenerating fibers of myeKlf2 -/-show more fibers with larger cross-sectional areas and fewer central nuclei.
Discussion
Acute skeletal muscle injury induces a robust immune response that is essential for the proper completion of repair [6] . This response follows a specific program of coordinated interactions between the immune system and the injured muscle.
Myeloid Functions of myeloid KLF2 in the immune response to skeletal muscle injury.
These findings indicate that the zinc-finger transcription factor, KLF2, either directly or indirectly, negatively regulates genes that determine myeloid cell phenotypes during skeletal muscle repair.
Injured skeletal muscles recruit mainly Ly6C + monocytes from the circulation [5] . IL-6 is secreted by inflammatory monocytes/macrophages and plays a central role in the inflammation phase of repair. The majority of the initial IL-6 pool is produced by monocytes recruited from the circulation [20] . IL-6 is also produced by activated satellite cells and this pool of IL-6 provides a key myokine for the formation and differentiation of new fibers [30] . Our finding that KLF2 negatively regulates IL-6 expression early in regenerating muscles is novel and may explain, in part, the ability of an enhanced is required for their proper migration [16] . CCR5 expression increases during differentiation of human monocytes and monocyte-derived macrophages [31, 32] . In atherosclerosis, the expression of CCR5 and CX3CR1 is required for Ly6C + monocytes to accumulate in plaques [33] .
The switch of macrophage phenotypes from Ly6C + to Ly6C -populations is required for regeneration to proceed [22, 34] . It is notable that the disappearance of Ly6C + macrophages and their replacement with Ly6C -macrophages persists in regenerating muscles of myeKlf2 -/-mice, indicating that myeloid KLF2 is not directly required for this transition. The transition may be driven by local signals related to phagocytosis, as suggested by Arnold et al [5] and as shown in other cell types [35] [36] [37] [38] .
The unique MerTK + population of macrophages that increases during this transition in myeKlf2 -/-muscles may contribute to resolving inflammation. MerTK is a member of the Tyro3/Axl/Mer (TAM) receptor tyrosine kinase family, whose functions in macrophages include phagocytosis of necrotic cells [39] and the subsequent dampening of inflammatory responses [40, 41] . After acute liver injury, an expanding population of monocyte-derived MerTK + macrophages clears damaged cellular material and also secretes anti-inflammatory mediators that help resolve inflammation [24] . In wound healing, the population of Ly6C -, MerTK + , F4/80 + macrophages increases as inflammation resolves and regeneration proceeds [25] . In cardiac muscle damaged by ischemia, MerTK promotes the resolution of inflammation and its loss compromises repair [42, 43] . Our findings identify MerTK as a KLF2-regulated receptor that influences the transition from inflammation to regeneration during skeletal muscle repair.
Key differences between myeloid KLF2 functions in skeletal muscle repair after acute injury, and its role in chronic inflammatory conditions. A more robust inflammatory phase of muscle regeneration in myeKlf2 -/-mice is consistent with known functions of myeloid KLF2 as a negative regulator of inflammatory genes and inflammatory immune cell profiles in other conditions [14] [15] [16] . Overexpression of KLF2 in leucocytes induces quiescence [44] and represses inflammatory genes [15] . In a mouse model of atherosclerosis, peritoneal macrophages of myeKlf2 -/-mice show a chronic inflammatory profile, produce elevated levels of cytokines, and show enhanced adhesion and infiltration into atherosclerotic lesions [18, 19] .
On the other hand, our finding that the inflammation in injured muscles resolves in the complete absence of KLF2 was unexpected. In atherosclerosis and other chronic inflammatory conditions, a reduction in KLF2 levels in macrophages promotes inflammatory gene expression, and a subsequent rise in KLF2 terminates their expression. When KLF2 levels cannot rise, the inflammation is enhanced and persists, and tissue damage worsens [19] . A different myeloid cell program must operate during skeletal muscle repair. When inflammatory gene expression is enhanced by deleting KLF2, inflammatory Ly6C + macrophages transition normally to an anti-inflammatory phenotype without the requirement for KLF2.
Therapeutic implications. Skeletal muscle injuries related to aging, disease and sports are the most common musculo-skeletal conditions reported worldwide. Severely injured skeletal muscle has limited ability to repair and regenerate. This study suggests a novel strategy for improving outcomes after muscle injury. Conventional treatments for muscle injuries seek to limit inflammation. Our findings suggest that enhancing a specific inflammatory program by manipulating KLF2 in myeloid lineage cells can accelerate regeneration. Myeloid KLF2 is an attractive therapeutic target for several reasons. Targeting a transcription factor, rather than a single chemokine or receptor, provides an opportunity to controls a cluster of interacting genes that determine macrophage phenotypes and functions. Importantly, myeloid KLF2 is accessible from the circulation and controls an early step of repair that positively drives the overall progress of regeneration. 
Conclusions
Material and Methods
Animals -Klf2 fl/fl mice were generated and backcrossed to a C57BL/6 background as described [19] . Klf2 fl/fl mice were crossed with transgenic mice expressing Cre recombinase under the control of the LysM promoter (LysM-cre, Jackson Laboratories;
[45] to produce offspring with a targeted deletion of KLF2 in all myeloid-derived cells. Muscle Injury -Acute injury was produced by injecting Cardiotoxin (CTX; EMD Millipore, 100 µl of 10 mM stock dissolved in PBS) into the gastrocnemius muscle. CTX
injury is an established model of skeletal muscle regeneration. It induces a reproducible sequence of changes that reflect the physiological repair process after traumatic injury [46] . The gastrocnemius muscle was surgically removed for analysis at time points up to 21 days post injury and the animals were sacrificed.
RNA isolation and real
time quantitative PCR (RT-qPCR) -Total RNA was isolated from skeletal muscle and macrophages using mirVana miRNA isolation kit (Invitrogen). cDNA was synthesized using the Superscript IV reverse-transcription system (Invitrogen, # 18091050) and genomic DNA was eliminated using EZDNASE (Invitrogen, # 11766051). mRNA expression was quantified using gene-specific Taqman primers and probes (Applied Biosystems) following the manufacturer's protocol, and normalized to 18sRNA levels. RT-qPCR was performed on an ABI7300 real A. Gastrocnemius muscles were obtained from WT and myeKlf2 -/-mice at days 3 and 5 post CTX injury and stained and sorted by flow cytometry using antibody against CCR5. The expression of CCR5 was increased in myeKlf2 -/-mice compared to WT on both the days tested (n=5, p<0.05 for days 3 and 5 post CTX).
B. Same strategy was followed and sorted by flow cytometry using antibody against CCR2 but there was no difference in expression between WT and myeKlf2 -/-mice (p = insignificant).
C.
Representative flow cytometry analysis for gastrocnemius muscles that were obtained from WT and myeKlf2 -/-mice at days 3 and 5 post CTX injury and stained and sorted using antibody against MerTK. The expression of CCR5 was increased in myeKlf2 -/-mice compared to WT on both the days tested (n=5, p<0.01 for days 3 and 5 post CTX). C.
